Duran, Claire .
HRN: 17-71-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/04/2024
12/05/2024
IV
1.5g
Q8
CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes